Provided by Tiger Trade Technology Pte. Ltd.

Corcept Therapeutics

121.19
+2.652.24%
Post-market: 121.190.00000.00%17:34 EDT
Volume:624.16K
Turnover:75.47M
Market Cap:13.10B
PE:267.14
High:122.34
Open:118.00
Low:117.41
Close:118.54
52wk High:126.38
52wk Low:28.66
Shares:108.10M
Float Shares:96.44M
Volume Ratio:0.80
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4537
EPS(LYR):0.8200
ROE:8.23%
ROA:0.47%
PB:18.56
PE(LYR):147.79

Loading ...

Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Major Issues Report

8-K - Current report
Feb 03, 2021

Major Issues Report

8-K - Current report
Jan 26, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 14, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 23, 2020

Major Issues Report

8-K - Current report
Nov 19, 2020

Major Issues Report

8-K - Current report
Nov 03, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2020

Major Issues Report

8-K - Current report
Oct 13, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 04, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2020

Major Issues Report

8-K - Current report
Jul 14, 2020

Major Issues Report

8-K - Current report
May 29, 2020

Major Issues Report

8-K - Current report
May 04, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 04, 2020

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Apr 09, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Mar 13, 2020

Major Issues Report

8-K - Current report